ST Pharm Co.Ltd Cash Flow Reinvestment Rate
ST Pharm Co.Ltd cash flow reinvestment rate. ST Pharm Co.Ltd (237690) has a Cash Flow Reinvestment Rate of 0.90x as of September 2025, reinvesting ₩26.39 Billion (capex ₩14.61 Billion plus investments ₩-11.79 Billion) from operating cash flow of ₩29.25 Billion. See ST Pharm Co.Ltd (237690) financial flexibility to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of ST Pharm Co.Ltd (2015–2025)
Cash flow reinvestment rate of ST Pharm Co.Ltd from 2015 to 2025. Historical reinvestment intensity for ST Pharm Co.Ltd across 9 annual periods. Explore 237690 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
ST Pharm Co.Ltd Cash Flow Reinvestment Rate by Year (2015–2025)
ST Pharm Co.Ltd cash flow reinvestment rate by year from 2015 to 2025. Year-by-year capital reinvestment analysis for ST Pharm Co.Ltd. For the full cash flow conversion analysis, see ST Pharm Co.Ltd (237690) cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 4.60x | ₩64.37 Billion | ₩13.99 Billion | ₩47.29 Billion | ▲ +196.7% |
| 2024 | 1.55x | ₩169.77 Billion | ₩109.45 Billion | ₩83.22 Billion | ▼ -98.4% |
| 2023 | 96.91x | ₩125.83 Billion | ₩1.30 Billion | ₩43.44 Billion | ▲ +926.4% |
| 2022 | 9.44x | ₩66.39 Billion | ₩7.03 Billion | ₩60.66 Billion | ▼ -27.2% |
| 2021 | 12.97x | ₩94.28 Billion | ₩7.27 Billion | ₩51.79 Billion | ▲ +400.0% |
| 2018 | 2.59x | ₩27.93 Billion | ₩10.77 Billion | ₩27.17 Billion | ▲ +408.8% |
| 2017 | 0.51x | ₩27.75 Billion | ₩54.44 Billion | ₩27.70 Billion | ▼ -62.0% |
| 2016 | 1.34x | ₩68.08 Billion | ₩50.78 Billion | ₩16.03 Billion | ▲ +24.8% |
| 2015 | 1.07x | ₩38.47 Billion | ₩35.82 Billion | ₩22.40 Billion | — |